Tag: Medical Equipment and Devices

Displaying 1 - 20 of 61 results.

Pages

The Federal Trade Commission issued a statement on its vote to close the investigation of the proposed merger of European eyewear makers Essilor and Luxottica Group.According to the statement, the evidence did not support a conclusion that Essilor’s proposed acquisition of Luxottica violates...
The Federal Trade Commission filed a complaint against the nation’s three largest dental supply companies alleging that they violated U.S. antitrust laws by conspiring to refuse to provide discounts to or otherwise serve buying groups representing dental practitioners.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that medical technology company Becton, Dickinson’s proposed $24 billion acquisition of competitor C. R. Bard would violate federal antitrust law by harming competition in two U.S.
Becton, Dickinson and Company and C. R. Bard, Inc. have agreed to divest two medical device product lines to settle Federal Trade Commission charges that Becton, Dickinson’s proposed $24 billion acquisition of Bard would negatively impact competition in those markets. Both companies supply a range...
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Integra LifeSciences Holdings Corp.’s $1 billion acquisition of Johnson & Johnson’s Codman Neuro division would negatively impact competition in those markets. Both companies supply...
The FTC issued an administrative complaint challenging the merger of two prosthetics manufacturers that are top sellers of prosthetic knees equipped with microprocessors. According to the FTC’s complaint, Otto Bock’s consummated acquisition of FIH Group Holdings (owner of Freedom...
Following a public comment period, the Federal Trade Commission has approved a final order designed to remedy the anticompetitive effects resulting from Abbott’s $8.3 billion acquisition of Alere.
Abbott Laboratories and Alere Inc. have agreed to a divestiture of two point-of-care medical device products line in order to settle Federal Trade Commission charges that Abbott’s proposed $8.3 billion acquisition of Alere will cause harm to competition.Abbott is a global healthcare company that...
Integra LifeSciences Holdings Corp. and Johnson & Johnson have agreed to a divestiture of five neurosurgical medical device product lines to settle Federal Trade Commission charges that Integra’s proposed $1 billion acquisition of Johnson & Johnson’s Codman Neuro division would negatively...
The Federal Trade Commission will host a workshop tomorrow in Washington, DC, to explore competition, innovation, and consumer protection issues raised by hearing health services and technology.The event is free and open to the public. It will be available via live webcast and live tweeted via...
The Federal Trade Commission has announced a final agenda for the Now Hear This: Competition, Innovation, and Consumer Protection Issues in Hearing Health Care workshop. The event will explore competition, innovation, and consumer protection issues raised by hearing health services and technology. 
Chirping birds, babbling brooks, soft rain showers, and children gleefully playing outdoors – these sounds of spring bring us joy, especially after a long winter. But for the millions of Americans who have hearing loss, full enjoyment of these and other everyday sounds can be out of...
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Abbott Laboratories’ $25 billion acquisition of St. Jude Medical, Inc. would likely be anticompetitive.

Pages